Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation.

MLA

Groetzner, Jan, et al. “Conversion to Sirolimus and Mycophenolate Can Attenuate the Progression of Bronchiolitis Obliterans Syndrome and Improves Renal Function after Lung Transplantation.” Transplantation, vol. 81, no. 3, Feb. 2006, pp. 355–60. EBSCOhost, https://doi.org/10.1097/01.tp.0000195781.02268.5e.

APA

Groetzner, J., Wittwer, T., Kaczmarek, I., Ueberfuhr, P., Strauch, J., Nagib, R., Meiser, B., Franke, U., Reichart, B., & Wahlers, T. (2006). Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation. Transplantation, 81(3), 355–360. https://doi.org/10.1097/01.tp.0000195781.02268.5e

Chicago

Groetzner, Jan, Thorsten Wittwer, Ingo Kaczmarek, Peter Ueberfuhr, Justus Strauch, Ragi Nagib, Bruno Meiser, Ulrich Franke, Bruno Reichart, and Thorsten Wahlers. 2006. “Conversion to Sirolimus and Mycophenolate Can Attenuate the Progression of Bronchiolitis Obliterans Syndrome and Improves Renal Function after Lung Transplantation.” Transplantation 81 (3): 355–60. doi:10.1097/01.tp.0000195781.02268.5e.